Compare CLIR & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLIR | NMTC |
|---|---|---|
| Founded | 2008 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.7M | 31.5M |
| IPO Year | 2012 | N/A |
| Metric | CLIR | NMTC |
|---|---|---|
| Price | $0.68 | $0.62 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $2.00 | ★ $2.23 |
| AVG Volume (30 Days) | 100.7K | ★ 198.6K |
| Earning Date | 11-14-2025 | 12-15-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $2,153,000.00 | ★ $6,629,051.00 |
| Revenue This Year | $13.13 | $162.84 |
| Revenue Next Year | $143.88 | $26.51 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 69.00 |
| 52 Week Low | $0.46 | $0.40 |
| 52 Week High | $1.72 | $1.39 |
| Indicator | CLIR | NMTC |
|---|---|---|
| Relative Strength Index (RSI) | 36.38 | 46.29 |
| Support Level | $0.58 | $0.55 |
| Resistance Level | $0.78 | $0.75 |
| Average True Range (ATR) | 0.06 | 0.05 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 31.00 | 54.70 |
ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.